Immunization and challenge experiments with a new modified live bovine herpesvirus type 1 marker vaccine prototype adjuvanted with a co-polymer

Vaccine

Volumn 28, Issue 36, 2010, Pages 5871-5877

  Kalthoff, Donata ^a   König, Patricia ^a   Trapp, Sascha ^b   Beer, Martin ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b College of Veterinary Medicine ^*  (United States)

Author keywords

Adjuvant; BoHV 1; Modified live vaccine

Indexed keywords

BOVINE HERPESVIRUS TYPE 1 LIVE VACCINE; COPOLYMER; HERPES VACCINE; LIVE VACCINE; PHARMACOLOGICAL BIOMARKER; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOVINE HERPESVIRUS TYPE 1 INFECTION; CONTROLLED STUDY; COW; FEMALE; HERPES VIRUS INFECTION; IMMUNIZATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; TREATMENT RESPONSE; TRIGEMINUS GANGLION; VIRUS GENOME; VIRUS STRAIN;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CATTLE; CATTLE DISEASES; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, BOVINE; HERPESVIRUS VACCINES; SEQUENCE DELETION; VIRAL PROTEINS; VIRUS SHEDDING;

EID: 77955559380     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.06.057     Document Type: Article

References (37)

1. Davison AJ, Eberle R, Ehlers B, Hayward GS, McGeoch DJ, Minson AC et al. Taxonomic proposals from the Herpesviridae study group. http://talk.ictvonline.org/files/ictv_official_taxonomy_updates_since_the_8th_report/m/vertebrate-2008/174.aspx.
2. Gibbs E.P.J., Rweyemamu M.M. Bovine herpesviruses. Part 1. Bovine herpesvirus 1. Vet Bull 1977, 47:317-343.
3. Kahrs R.F. Infectious bovine rhinotracheitis: a review and update. J Am Vet Med Assoc 1977, 171:1055-1064.
4. Strube W., Auer S., Block W., et al. A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs. Vet Microbiol 1996, 53:181-189.
5. de Wit J.J., Hage J.J., Brinkhof J., Westenbrink F. A comparative study of serological tests for use in the bovine herpesvirus 1 eradication programme in The Netherlands. Vet Microbiol 1998, 61:153-163.
6. Stegeman JA. Pseudorabies virus eradication by area-wide vaccination is feasible. PhD-thesis. Utrecht University, The Netherlands; 1995.
7. van Oirschot J.T., Kaashoek M.J., Rijsewijk F.A., Stegemann J.A. The use of marker vaccines in eradication of herpesviruses. J Biotechnol 1996, 44(1-3):75-81.
8. van Oirschot J.T., Kaashoek M.J., Maris-Veldhuis M.A., Weerdmeester K., Rijsewijk F.A. An enzyme-linked immunosorbent assay to detect antibodies against glycoprotein gE of bovine herpesvirus 1 allows differentiating between infected and vaccinated cattle. J Virol Methods 1997, 67(1):23-34.
9. Bosch J.C., Kaashoek M.J., Kroese A.H., van Oirschot J.T. An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines. Vet Microbiol 1996, 52(3-4):223-234.
10. Mars M.H., de Jong M.C., Franken P., van Oirschot J.T. Efficacy of a live glycoprotein E-negative bovine herpesvirus 1 vaccine in cattle in the field. Vaccine 2001, 19(15-16):1924-1930.
11. Bosch J.C., De Jong M.C., Franken P., Frankena K., Hage J.J., Kaashoek M.J., et al. An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the field. Vaccine 1998, 16(2-3):265-271.
12. Straub O.C. Experience with two BHV1 marker vaccines. Proceedings of the 19th congress of the World Association for Buiatrics 1996.
13. Lemaire M., Schynts F., Meyer G., Georgin J.P., Baranowski E., Gabriel A., et al. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies. Vaccine 2001, 19(32):4795-4804.
14. Dispas M., Schynts F., Lemaire M., Letellier C., Vanopdenbosch E., Thiry E., et al. Isolation of a glycoprotein E-deleted bovine herpesvirus type 1 strain in the field. Vet Rec 2003, 153(7):209-212.
15. Muylkens B., Meurens F., Schynts F., de Fays K., Pourchet A., Thiry J., et al. Biological characterization of bovine herpesvirus 1 recombinants possessing the vaccine glycoprotein E negative phenotype. Vet Microbiol 2006, 113(3-4):283-291.
16. Kaashoek M.J., van Engelenburg F.A.C., Moerman A., Gielkens A.L.J., Rijsewijk F.A.M., van Oirschot J.T. Virulence and immunogenicity in calves of thymidine kinase- and glycoprotein E-negative bovine herpesvirus 1 mutants. Vet Microbiol 1996, 48(1-2):143-153.
17. Matheka H.D., Straub O.C. Weitere Untersuchungen zur Differenzierung des Virus der Rhinotracheitis (IBR) vom Virus des Bläschenausschlages (IPV) durch die trägerfreie Zonenelektrophorese in einem Glukose-Dichtegradienten. Archiv Gesamte Virusforsch 1972, 39:265-273.
18. van Drunen Littel-van den Hurk S., Snider M., Thompson P., Latimer L., Babiuk L.A. Strategies for induction of protective immunity to bovine herpesvirus-1 in newborn calves with maternal antibodies. Vaccine 2008, 26(25):3103-3111.
19. van Drunen Littel-van den Hurk S. Rationale and perspectives on the success of vaccination against bovine herpesvirus-1. Vet Microbiol 2006, 113(3-4):275-282.
20. Zimmerman A.D., Boots R.E., Valli J.L., Chase C.C.L. Evaluation of protection against virulent bovine viral diarrhea virus type 2 in calves that had maternal antibodies and were vaccinated with a modified-live vaccine. J Am Vet Med Assoc 2006, 228(11):1757-1761.
21. Trapp S., Osterrieder N., Keil G.M., Beer M. Mutagenesis of a bovine herpesvirus type 1 genome cloned as an infectious artificial chromosome: analysis of glycoprotein E and G double deletion mutants. J Gen Virol 2003, 84(Pt 2):301-306.
22. Lee E.C., Yu D., Martinez de Velasco J., Tessarollo L., Swing D.A., Court D.L., et al. A highly efficient Escherichia coli-based chromosomal engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 2001, 73(1):56-65.
23. Datsenko K.A., Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 2000, 97(12):6640-6645.
24. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: a laboratory manual 1989, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 2nd ed.
25. Neubauer A., Braun B., Brandmüller C., Kaaden O.R., Osterrieder N. Analysis of the contributions of the equine herpesvirus 1 glycoprotein gB homolog to virus entry and direct cell-to-cell spread. Virology 1997, 227(2):281-294.
26. Highlander S.L., Sutherland S.L., Gage P.J., Johnson D.C., Levine M., Glorioso J.C. Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. J Virol 1987, 61(11):3356-3364.
27. Makoschey B., Keil G.M. Early immunity induced by a glcyoprotein E-negative vaccine for infectious bovine rhinotracheitis. Vet Rec 2000, 147:189-191.
28. Hoffmann B., Depner K., Schirrmeier H., Beer M. A universal heterologous internal control system for duplex real-time RT-PCR assays used in a detection system for pestiviruses. J Virol Methods 2006, 136(1-2):200-209.
29. Shams H. Recent developments in veterinary vaccinology. Vet J= 2005, 170(3):289-299.
30. Mahon B.P. The rational design of vaccine adjuvants for mucosal and neonatal immunization. Curr Med Chem 2001, 8(9):1057-1075.
31. Mena A., Ioannou X.P., Van Kessel A., Van Drunen Little-Van Den Hurk S., Popowych Y., Babiuk L.A., et al. Th1/Th2 biasing effects of vaccination in cattle as determined by real-time PCR. J Immunol Methods 2002, 263(1-2):11-21.
32. Lutsiak M.E., Kwon G.S., Samuel J. Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses. J Pharm Pharmacol 2006, 58(6):739-747.
33. Patterson P.S., Bosshardt S.C., Udhayukumar V., Xiao L., Kidd M., Hunter R.L., et al. Prolonged expression of IFNgamma induced by protective blood-stage immunization against Plasmodium yoelii malaria. Vaccine 2000, 18(1-2):173-180.
34. Visser N. Vaccination strategies for improving the efficacy of programs to eradicate Aujeszky's disease virus. Vet Microbiol 1997, 55(1-4):61-74.
35. Beer M., Konig P., Schielke G., Trapp S. Diagnostic markers in the prevention of bovine herpesvirus type 1: possibilities and limitations. Berl Munch Tierarztl Wochenschr 2003, 116(5-6):183-191.
36. Toussaint J.F., Rziha H.J., Bauer B., Letellier C., Kerkhofs P. Effects of hypervaccination with bovine herpesvirus type 1 gE-deleted marker vaccines on the serological response and virological status of calves challenged with wild-type virus. Vet Rec 2004, 155(18):553-558.
37. Nettleton P.F., Sharp J.M. Infectious bovine rhinotracheitis virus excretion after vaccination. Vet Rec 1980, 107(16):379.